文献检索/Drug SafetyEM-T3Drug Safety2018-12-18第 42 卷第 5 期，587-601开放获取高影响力 · 前 10%Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaAnthony Selwyn SteinCity Of Hope National Medical CenterJanet L. FranklinAmgen (United States)Victoria M. ChiaAmgen (United States)Deborah ArrindellAmgen (United States)William N. KormanyAmgen (United States)Jacqueline WrightAmgen (United States)Mandy ParsonAmgen (United States)Hamid R. AmouzadehAmgen (United States)Jessica ChoudhryAmgen (United States)Guiandre L. JosephAmgen (United States)开放获取全文去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词blinatumomabrisk-benefit assessmentPhiladelphia chromosome-positive ALLminimal residual diseasecytokine release syndromeneurotoxicitymedication errorsCAR T-cell therapyhematologic remissionoverall survival参考文献35引证文献0相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
